Prevest DenPro Limited reported a 17.7% increase in net profit to ₹2,141.82 lakh for the financial year ended March 31, 2026, compared to ₹1,820.13 lakh in the previous year. Revenue from operations for the year rose 13.6% to ₹7,166.42 lakh from ₹6,306.77 lakh in FY25. The board of directors approved the audited standalone and consolidated financial results at a meeting held on May 27, 2026.

The company's total income for FY26 stood at ₹7,666.12 lakh, up from ₹6,717.76 lakh in the previous year. For the quarter ended March 31, 2026, net profit increased to ₹606.37 lakh from ₹524.76 lakh in the corresponding quarter of the previous year. Revenue for the quarter was ₹1,890.40 lakh, compared to ₹1,854.25 lakh in Q4FY25.

Financial Performance

The earnings per share (EPS) for the year improved to ₹17.84 from ₹15.16 in the previous year. The company's reserves and surplus increased to ₹11,382.01 lakh as of March 31, 2026, from ₹9,360.22 lakh a year earlier. Total assets stood at ₹13,424.46 lakh, compared to ₹11,267.48 lakh in the prior year.

Auditor's Report

Mittal & Associates, Chartered Accountants, issued an audit report with an unmodified opinion on the standalone and consolidated financial results. The report confirmed that the statements give a true and fair view of the company's financial position. The auditors noted that the financial results were prepared in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The trading window for dealing in the company's securities, which was closed since April 01, 2026, will reopen 48 hours after the financial results are declared to the stock exchanges.

Prevest denpro Limited has announced a change in its board composition with the cessation of an Independent Director upon completion of tenure. The company filed the necessary regulatory disclosure on April 27, 2026, informing the stock exchanges about this scheduled board change.

Director Cessation Details

Mr. Pardeep Gandotra (DIN: 08733719) ceased to hold office as Independent Director of the company effective from the closure of business hours on April 26, 2026. The cessation occurred due to the natural completion of his tenure as an Independent Director, marking the end of his scheduled term with the company.

Regulatory Compliance

The company fulfilled its regulatory obligations by filing the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made in accordance with SEBI Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Managing Director Atul Modi (DIN: 00788272) signed the disclosure document on behalf of Prevest Denpro Limited. The company has also committed to making this information available on its official website for stakeholder reference.

Corporate Governance Impact

The cessation represents a routine board transition as Independent Directors serve fixed terms under corporate governance norms. The completion of Mr. Gandotra's tenure follows the standard practice of Independent Director appointments, which are subject to specific tenure limits as per regulatory requirements.